CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenue:
Total revenue	$ 100,283	$ 99,898	$ 188,915	$ 177,397
Amortization of acquired intangible assets	6,547	6,440	13,022	12,880
Gross profit	83,146	84,986	156,461	145,074
Operating expenses:
Selling, general and administrative	26,412	27,740	53,903	58,145
Research and development	7,983	2,560	12,379	6,438
Total operating expenses	34,395	30,300	66,282	64,583
Income from operations	48,751	54,686	90,179	80,491
Changes in fair values of equity method investments, net	13,082	(60,108)	(467)	(24,766)
Changes in fair values of equity and long-term investments, net	11,280	(30,556)	(54,019)	(43,891)
Interest and dividend income	4,925	3,474	9,463	7,873
Interest expense	(4,663)	(5,802)	(9,374)	(11,653)
Other expense, net	(777)	(973)	(1,773)	(2,209)
Income (loss) before income taxes	72,598	(39,279)	34,009	5,845
Income tax benefit (expense), net	(8,910)	4,594	(16,905)	(3,998)
Net income (loss) and comprehensive income (loss)	$ 63,688	$ (34,685)	$ 17,104	$ 1,847
Net income (loss) per share:
Basic	$ 1.01	$ (0.55)	$ 0.27	$ 0.03
Diluted	$ 0.77	$ (0.55)	$ 0.24	$ 0.03
Shares used to compute net income (loss) per share:
Basic	62,865	62,526	62,787	62,856
Diluted	84,452	62,526	84,342	63,064
Royalty Revenue
Revenue:
Total revenue	$ 63,880	$ 63,742	$ 121,687	$ 122,157
Net product sales
Revenue:
Total revenue	35,493	21,651	65,772	40,735
Cost of products sold (inclusive of amortization of inventory fair value adjustments)	10,590	8,472	19,432	19,443
License and other revenue
Revenue:
Total revenue	$ 910	$ 14,505	$ 1,456	$ 14,505